Welcome to BioMarket Group!

The increasing importance of CRM in the pharma industry (Technology Focus)

Additional Information

Published Date Aug 13, 2007
Special Offer No
Pages 13
PDF Fact Sheet View Fact Sheet for the report The increasing importance of CRM in the pharma industry (Technology Focus) in PDF format.
Published on Date No
Format PDF
Publisher Datamonitor
Product Line No
Full Title The increasing importance of CRM in the pharma industry (Technology Focus)

Availability: In stock

$1,895.00

Quick Overview

Due to the unique nature of the pharmaceutical industry there are a number of challenges to be overcome in the installation of CRM solutions.
Request free sample pages from The increasing importance of CRM in the pharma industry (Technology Focus)

Introduction

This report looks into which CRM technologies are going to develop and how vendors can help pharma companies meet their challenges through the successful implementation of CRM.

Scope

Vendors need to help pharma companies create unified enterprise wide CRM solutions. Analytical CRM is going to continue to increase in importance for the pharma industry. M&A activity creates specific challenges for the integration of technology within pharma companies.

Highlights

Mobile devices and analytical CRM are going to continue to be of increasing importance. This report looks into how vendors can help ensure successful implementations take place.

Reasons to Purchase

Learn which areas of CRM are going to continue to be of importance. Understand the technology challenges that need to be met to ensure CRM solutions are successful. Learn how vendors can remain strong with the CRM in pharma market.

Request free sample pages from The increasing importance of CRM in the pharma industry (Technology Focus)

Other selected research from the 'Business Development' category:


Partneringdesk Baxter International, Inc. and Company Deals Briefing
Comprehensive summary of the last 5 years of deal-making by the industry’s top 50 pharmaceutical and biotech companies. Learn More


Partnering Agreements with Daiichi Sankyo 2010
The Partnering Agreements with Daiichi Sankyo 2010 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand Daiichi Sankyo Labs and its partnering interests and activities over the past five years.
Learn More

Other selected research from the 'Markets' category:


The Pharmaceutical Company Outlook to 2011: Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
Based on an analysis of 46 companies and 1,000+ products, Datamonitor forecasts that pharmaceutical industry ethical sales will increase at a modest 4.9% CAGR 200511. However, behind this industry average figure there are strategic segments of the market that offer double-digit growth rates through barriers against generic competition and the opportunity for aggressive indication broadening. Learn More


Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)
This report offers insight into PLM in the pharmaceutical industry, bringing together all research published for this theme. Learn More